Your Input: | |||||
MAPK1 | Mitogen-activated protein kinase; Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. MAP kinase subfamily. (396 aa) | ||||
MAPK14 | Mitogen-activated protein kinase. (350 aa) | ||||
JUN | Jun proto-oncogene, AP-1 transcription factor subunit; Belongs to the bZIP family. (335 aa) | ||||
LOC108633189 | Uncharacterized protein. (241 aa) | ||||
RB1 | RB transcriptional corepressor 1. (931 aa) | ||||
HRAS | HRas proto-oncogene, GTPase. (189 aa) | ||||
CDKN1A | Cyclin dependent kinase inhibitor 1A. (161 aa) | ||||
RAF1 | Raf-1 proto-oncogene, serine/threonine kinase. (648 aa) | ||||
E2F2 | E2F transcription factor 2. (437 aa) | ||||
CARM1 | Coactivator associated arginine methyltransferase 1; Belongs to the class I-like SAM-binding methyltransferase superfamily. Protein arginine N-methyltransferase family. (608 aa) | ||||
DLL3 | Delta like canonical Notch ligand 3. (595 aa) | ||||
NCOR1 | Nuclear receptor corepressor 1. (2447 aa) | ||||
CCND1 | Cyclin D1; Belongs to the cyclin family. (295 aa) | ||||
E2F3 | E2F_TDP domain-containing protein. (460 aa) | ||||
SHC3 | SHC adaptor protein 3. (592 aa) | ||||
ADCY9 | Adenylate cyclase 9; Belongs to the adenylyl cyclase class-4/guanylyl cyclase family. (1354 aa) | ||||
ESR2 | Uncharacterized protein. (527 aa) | ||||
ADCY6 | Adenylate cyclase type 6; Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. (1172 aa) | ||||
LOC102188874 | Uncharacterized protein. (394 aa) | ||||
MAPK10 | Mitogen-activated protein kinase. (426 aa) | ||||
SP1 | Uncharacterized protein. (786 aa) | ||||
SHC1 | SHC adaptor protein 1. (583 aa) | ||||
SHC4 | SHC adaptor protein 4. (630 aa) | ||||
MAPK9 | Mitogen-activated protein kinase. (424 aa) | ||||
PTK2 | Protein tyrosine kinase 2; Belongs to the protein kinase superfamily. Tyr protein kinase family. (1095 aa) | ||||
ESR1 | Estrogen receptor; The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. (596 aa) | ||||
MAP2K2 | Protein kinase domain-containing protein; Belongs to the protein kinase superfamily. (400 aa) | ||||
AKT2 | Non-specific serine/threonine protein kinase; Belongs to the protein kinase superfamily. (482 aa) | ||||
BAD | BCL2 associated agonist of cell death. (198 aa) | ||||
E2F1 | E2F transcription factor 1. (441 aa) | ||||
PIK3R3 | Uncharacterized protein. (461 aa) | ||||
JAG2 | Delta-like protein; Putative Notch ligand involved in the mediation of Notch signaling. (1069 aa) | ||||
CDKN1B | Cyclin dependent kinase inhibitor 1B. (198 aa) | ||||
GRB2 | Growth factor receptor bound protein 2. (217 aa) | ||||
MAPK3 | Mitogen-activated protein kinase; Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. MAP kinase subfamily. (380 aa) | ||||
PIK3CA | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit. (1068 aa) | ||||
MMP2 | Matrix metallopeptidase 2. (661 aa) | ||||
BCL2 | BH4_2 domain-containing protein. (229 aa) | ||||
BAX | BCL2 associated X, apoptosis regulator. (192 aa) | ||||
PRKACA | Protein kinase cAMP-activated catalytic subunit alpha; Belongs to the protein kinase superfamily. (360 aa) | ||||
MMP9 | Uncharacterized protein. (709 aa) | ||||
NOTCH3 | Notch receptor 3. (2332 aa) | ||||
NCOA3 | Nuclear receptor coactivator. (1471 aa) | ||||
CDKN2C | Cyclin dependent kinase inhibitor 2C. (168 aa) | ||||
SOS1 | SOS Ras/Rac guanine nucleotide exchange factor 1. (1318 aa) | ||||
IGF1 | Insulin-like growth factor I; The insulin-like growth factors, isolated from plasma, are structurally and functionally related to insulin but have a much higher growth-promoting activity. May be a physiological regulator of [1-14C]- 2-deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblasts. Stimulates glucose transport in bone-derived osteoblastic (PyMS) cells and is effective at much lower concentrations than insulin, not only regarding glycogen and DNA synthesis but also with regard to enhancing glucose uptake. May play a role in synapse maturation. Ca(2+)-dependent exo [...] (188 aa) | ||||
PIK3CB | Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta; Belongs to the PI3/PI4-kinase family. (1070 aa) | ||||
MDM2 | E3 ubiquitin-protein ligase Mdm2; Belongs to the MDM2/MDM4 family. (491 aa) | ||||
MTOR | Serine/threonine-protein kinase mTOR; Belongs to the PI3/PI4-kinase family. (2550 aa) | ||||
PIK3CD | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit. (1044 aa) | ||||
CDK4 | Cyclin dependent kinase 4; Belongs to the protein kinase superfamily. (303 aa) | ||||
EGFR | Receptor protein-tyrosine kinase. (1208 aa) | ||||
ADCY4 | Adenylate cyclase type 4; Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. (1083 aa) | ||||
JAG1 | Delta-like protein; Putative Notch ligand involved in the mediation of Notch signaling. (1218 aa) | ||||
ABCB11 | ATP binding cassette subfamily B member 11. (1326 aa) | ||||
PIK3R1 | Phosphoinositide-3-kinase regulatory subunit 1. (724 aa) | ||||
GPER1 | G protein-coupled estrogen receptor 1; Belongs to the G-protein coupled receptor 1 family. (363 aa) | ||||
NOTCH2 | Notch receptor 2. (2471 aa) | ||||
HBEGF | Heparin binding EGF like growth factor. (208 aa) | ||||
ARAF | A-Raf proto-oncogene, serine/threonine kinase. (611 aa) | ||||
ADCY5 | Adenylate cyclase type 5; Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. (1259 aa) | ||||
NRAS | NRAS proto-oncogene, GTPase. (189 aa) | ||||
AKT1 | Non-specific serine/threonine protein kinase; Belongs to the protein kinase superfamily. (495 aa) | ||||
ADCY2 | Adenylate cyclase type 2; Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. (1091 aa) | ||||
MAPK13 | Mitogen-activated protein kinase. (366 aa) | ||||
IGF1R | Tyrosine-protein kinase receptor. (1367 aa) | ||||
MED1 | Mediator of RNA polymerase II transcription subunit 1; Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene- specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. (1577 aa) | ||||
PRKACB | Protein kinase cAMP-activated catalytic subunit beta; Belongs to the protein kinase superfamily. (397 aa) | ||||
ADCY1 | Adenylate cyclase type 1; Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. (1134 aa) | ||||
TP53 | Cellular tumor antigen p53; Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression; Belongs to the p53 family. (382 aa) | ||||
ADCY7 | Adenylate cyclase type 7; Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. (1230 aa) | ||||
AKT3 | Non-specific serine/threonine protein kinase; Belongs to the protein kinase superfamily. (481 aa) | ||||
FOS | Fos proto-oncogene, AP-1 transcription factor subunit. (380 aa) | ||||
MAPK8 | Mitogen-activated protein kinase. (442 aa) | ||||
SOS2 | SOS Ras/Rho guanine nucleotide exchange factor 2. (1332 aa) | ||||
ADCY3 | Adenylate cyclase type 3; Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. (1148 aa) | ||||
ERBB2 | Receptor protein-tyrosine kinase. (1250 aa) | ||||
ADCY8 | Adenylate cyclase type 8; Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. (1255 aa) | ||||
KRAS | KRAS proto-oncogene, GTPase. (189 aa) |